secwatch.observer — SEC 8-K summary
======================================

Issuer:     VIVEVE MEDICAL, INC. (—)
CIK:        0000879682
Form:       8-K
Filed at:   2022-12-02T23:59:59+00:00
Accession:  0001437749-22-028334
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Viveve Medical receives Nasdaq delisting notice for bid price and equity non-compliance
--------------------------------------------------------------------------------

- Nasdaq Staff notified Viveve on Nov 29, 2022 of delisting for failing Bid Price Rule and Equity Rule.
- Company failed to regain compliance with $1.00 minimum bid price by Nov 28, 2022 grace period end.
- Stockholders' equity as of Sep 30, 2022 fell below $2.5M minimum, triggering second delisting basis.
- Viveve intends to request a hearing before Nasdaq Hearings Panel to stay delisting.
- Plan to regain compliance may include fundraising and reverse stock split, but no assurance of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/879682/000143774922028334/0001437749-22-028334-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/879682/000143774922028334/vive20221201_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-028334

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer